-
Published 4/19/2025
Noyes E, Hausman E, Yeo EJ, Bain PA, Bannister M, Lopez IB, Rajakumar B, Wang G, Chatterjee A. Harm reduction interventions for AYA who use opioids: A scoping review. Drug Alcohol Depend. 2025 Apr 19; 272:112677. PMID: 40339383.
-
Published 1/23/2025
Zaragoza S, Silcox J, Rapisarda S, Summers C, Case P, To C, Chatterjee A, Walley AY, Komaromy M, Green TC. Developing a comprehensive inventory to define harm reduction housing. Harm Reduct J. 2025 Jan 23; 22(1):11. PMID: 39849487.
-
Published 11/29/2024
Johnson NL, Beaugard CA, Heredia-Perez D, So-Armah K, Reason P, Yule AM, Lee CS, Chapman SE, Chatterjee A, McClay C, Weeden T, Becerril C, Thomas D, Komaromy M. Embracing anti-racism: Co-creating recommendations with Black people for how addiction treatment needs to change. Soc Sci Med. 2025 Jan; 364:117433. PMID: 39615095.
-
Published 10/25/2024
Zang X, Skinner A, Li Z, Shaw LC, Behrends CN, Chatterjee A, Jalali A, Jordan AE, Morgan JR, Nolen S, Schackman BR, Marshall BDL, Walley AY. Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United States. Addiction. 2025 Feb; 120(2):316-326. PMID: 39450522.
-
Published 10/15/2024
Zaragoza S, Silcox J, Rapisarda S, Summers C, Case P, To C, Chatterjee A, Walley A, Komaromy M, Green T. Developing a Comprehensive Inventory to Define Harm Reduction Housing. Res Sq. 2024 Oct 15. PMID: 39483918.